

(ShareCast News) - Hutchison China MediTech reported its interim results for the six months to 30 June on Tuesday, with group revenue up 27% to $104.5...


(ShareCast News) - Healthcare group Hutchison China MediTech (Chi-Med) announced on Monday the start of a Phase II expansion of its ongoing TATTON tri...


By Alasdair Pal and Patrick Graham LONDON, May 23 (Reuters) - Almost two-thirds of the advisory firms who assist in stock exchange listings in London ...


(ShareCast News) - Hutchison China MediTech announced on Friday that it has completed patient enrolment of FRESCO, its Phase III trial of fruquintinib...

